Unknown

Dataset Information

0

Genome-wide miRNA response to anacardic acid in breast cancer cells.


ABSTRACT: MicroRNAs are biomarkers and potential therapeutic targets for breast cancer. Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor ? (ER?) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC50s of 13.5 and 35 ?M, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24:1n5 congener. Whole genome expression profiling (RNA-seq) and subsequent network analysis in MetaCore Gene Ontology (GO) algorithm was used to characterize the biological pathways altered by AnAc. In MCF-7 cells, 69 AnAc-responsive miRNAs were identified, e.g., increased let-7a and reduced miR-584. Fewer, i.e., 37 AnAc-responsive miRNAs were identified in MDA-MB-231 cells, e.g., decreased miR-23b and increased miR-1257. Only two miRNAs were increased by AnAc in both cell lines: miR-612 and miR-20b; however, opposite miRNA arm preference was noted: miR-20b-3p and miR-20b-5p were upregulated in MCF-7 and MDA-MB-231, respectively. miR-20b-5p target EFNB2 transcript levels were reduced by AnAc in MDA-MB-231 cells. AnAc reduced miR-378g that targets VIM (vimentin) and VIM mRNA transcript expression was increased in AnAc-treated MCF-7 cells, suggesting a reciprocal relationship. The top three enriched GO terms for AnAc-treated MCF-7 cells were B cell receptor signaling pathway and ribosomal large subunit biogenesis and S-adenosylmethionine metabolic process for AnAc-treated MDA-MB-231 cells. The pathways modulated by these AnAc-regulated miRNAs suggest that key nodal molecules, e.g., Cyclin D1, MYC, c-FOS, PPAR?, and SIN3, are targets of AnAc activity.

SUBMITTER: Schultz DJ 

PROVIDER: S-EPMC5590942 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genome-wide miRNA response to anacardic acid in breast cancer cells.

Schultz David J DJ   Muluhngwi Penn P   Alizadeh-Rad Negin N   Green Madelyn A MA   Rouchka Eric C EC   Waigel Sabine J SJ   Klinge Carolyn M CM  

PloS one 20170908 9


MicroRNAs are biomarkers and potential therapeutic targets for breast cancer. Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor α (ERα) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC50s of 13.5 and 35 μM, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24:1n5 congener. Whole  ...[more]

Similar Datasets

| S-EPMC5966448 | biostudies-literature
| S-ECPF-GEOD-55432 | biostudies-other
| S-EPMC6129544 | biostudies-literature
| S-EPMC4055655 | biostudies-literature
| S-ECPF-GEOD-59198 | biostudies-other
| S-EPMC1913522 | biostudies-literature
| S-ECPF-TABM-1194 | biostudies-other
| S-EPMC6827104 | biostudies-literature
| S-EPMC2837512 | biostudies-literature
| S-EPMC3977241 | biostudies-literature